Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced that 11 studies featuring the Breast Cancer Index® (BCItm) Test will be presented at the 2025 San Antonio Breast Cancer ...
Cells frequently encounter conditions that can damage them or even lead to cell death. To keep functioning, they must rapidly ...